First patient randomized in a groundbreaking skin cancer trial

We randomized our first patient in a skin cancer trial exploring a new injection-based treatment. For patients who have been through multiple Mohs surgeries and the wear of a repetitive process, this study points toward a less invasive and more sustainable option.

This marks a milestone not just for our team, but for patients seeking new options beyond repeated procedures. We are proud to contribute to research that can change how a condition is treated.

All news